AEON Biopharma
AEON
AEON
85 hedge funds and large institutions have $248M invested in AEON Biopharma in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
19% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 16
Holders
85
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.78M | |
| 2 | +$5.56M | |
| 3 | +$5.31M | |
| 4 |
D.E. Shaw & Co
New York
|
+$3.91M |
| 5 |
DFCM
Dark Forest Capital Management
San Juan,
Puerto Rico
|
+$3.04M |
Top Sellers
| 1 | -$4.68M | |
| 2 | -$4.16M | |
| 3 | -$3.87M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$3.43M |
| 5 |
Calamos Advisors
Naperville,
Illinois
|
-$2.46M |